Giotrif: new oral therapy for metastatic lung cancerTargeted treatment improves progression-free survival and disease related symptoms. Earlier access to palliative care teams helps patients with advanced cancer copeStudy finds quicker access improves quality of life and satisfaction with care. Hormone therapy for breast cancer: When is five years enough? Ten-year treatment adds little benefit in early disease Prostate cancer treatment takes its toll Avoid over-treating and watch for complications, researcher says Unnecessary tests driving thyroid cancer epidemic Diagnosis rates vary widely but mortality remains constant Concern raised over stroke risk with aromatase inhibitors Manitoba registry turns up findings not seen in trials Chemo-trastuzumab tops in HER2-positive breast cancer Survival results are some of the best ever seen, researcher says Excitement grows over gene therapy for cancer Reprogrammed cells fight leukemia and lymphoma Telemedicine takes cancer care closer to home Radiation oncology program bridges gap between northern cities Kadcyla for metastatic breast cancer First antibody–drug conjugate targeted therapy to be marketed in Canada. First Previous 40 41 42 43 44 Next Last
